Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Laboratory Corporation of America Holdings (LH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Laboratory America's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
208.18 +5.11    +2.52%
15:17:11 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 535,579
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 204.30 - 210.63
Laboratory America 208.18 +5.11 +2.52%

Laboratory Corporation of America Holdings Company Profile

 
Get an in-depth profile of Laboratory Corporation of America Holdings, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

67000

Equity Type

ORD

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Contact Information

Address 358 South Main Street
Burlington, 27215
United States
Phone 336 229 1127
Fax -

Top Executives

Name Age Since Title
Adam H. Schechter 57 2013 President, CEO & Chairman
Kathryn E. Wengel 56 2021 Independent Director
Kirsten Kliphouse - 2022 Independent Director
Paul B. Rothman 65 2023 Director
D. Gary Gilliland 68 2014 Independent Director
Garheng Kong 48 2013 Lead Independent Director
R. Sanders Williams 74 2007 Independent Director
Jean-Luc Belingard 75 1995 Independent Director
Kerrii B. Anderson 66 2006 Independent Director
Jeffrey A. Davis 60 2019 Independent Director
Richelle P. Parham 55 2016 Independent Director
Peter M. Neupert 67 2013 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LH Comments

Write your thoughts about Laboratory Corporation of America Holdings
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rajesh Patel
Rajesh Patel Nov 30, 2022 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
238
ItisOK Fornow
ItisOK Nov 19, 2020 3:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is the talk on LH?
Farry Hardianto
Farry Hardianto Jul 27, 2020 4:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Last call!
George Hayes
George Hayes Jul 21, 2020 11:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No raises, no matching retirement, reducing workforce...might not be good for employees, but the stock is rising...glad I'm retired, cause they don't care about the workers. But I've made about 10G the last 4 months.
Zohaib Khan
Zohaib Khan Jul 10, 2020 5:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one of the good stocks that can give profit.  I am holding with profit. Hope it will reach above 220
Farry Hardianto
Farry Hardianto Jul 10, 2020 5:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Before end of July your hope will come true.
George Hayes
George Hayes Jul 10, 2020 5:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
me too.
Willie Scott
Willie Scott Apr 25, 2020 2:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am so impressed with the performance of this stock... making money... it so much fun
Rose Za
Rose Za Apr 24, 2020 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great Job! time to buy it ...
Maurice No
Maurice No Mar 06, 2020 7:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They may profit from all this...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email